XIAO Zhijun, GUO Jiewen, XU Feng. Effect of litchi saponin and litchi flavones on insulin resistance in HepG2 cells[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(4): 316-318,350. doi: 10.3969/j.issn.1006-0111.2015.04.007
Citation:
|
XIAO Zhijun, GUO Jiewen, XU Feng. Effect of litchi saponin and litchi flavones on insulin resistance in HepG2 cells[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(4): 316-318,350. doi: 10.3969/j.issn.1006-0111.2015.04.007
|
Effect of litchi saponin and litchi flavones on insulin resistance in HepG2 cells
- 1.
Department of Pharmacy, Fengxian Central Hospital, Shanghai 201400, China
- 2.
Guangzhou Hospital of Traditional Chinese Medicine, Guangzhou 510130, China
- Received Date: 2015-04-22
- Rev Recd Date:
2015-06-06
-
Abstract
Objective To study the effect of litchi saponin and flavones on glycometabolism in insulin resistance model of HepG2 cells. Methods Using high insulin in HepG2 cells to establish a cell model of insulin resistance. Cell model was treated by litchi saponin, litchi flavones and rosiglitazone, respectively. Glucose concentration of cell culture supernatant was detected by glucose oxidase method. Results In the concentration of 10-6 mol/L insulin for 24 hours, HepG2 reached the highest level of resistant to insulin, which means a successful insulin resistance cell model was established. However, no significant decrease in glucose concentration of cell culture supernatant was observed with litchi saponin and flavones. Conclusion This study suggests that litchi saponin and flavones have no effect to improve insulin resistance.
-
References
[1]
|
Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links[J]. Cell,2012,148(5):852-871. |
[2]
|
Li GQ, Kam A, Wong KH, et al. Herbal medicines for the management of diabetes[J]. Adv Exp Med Biol,2012,771:396-413. |
[3]
|
郭洁文,潘竞锵. 荔枝和荔枝核的化学成分、生物活性及药理作用研究[J]. 中国新药杂志,2006,15(8):585-588. |
[4]
|
郭洁文,李丽明,潘竞锵,等. 荔枝核拮抗2型糖尿病大鼠胰岛素抵抗作用的药理学机制[J]. 中药材,2004,27(6):435-438. |
[5]
|
郭洁文,廖惠芳,潘竞锵,等. 荔枝核皂苷改善地塞米松致大鼠胰岛素抵抗作用机制研究[J]. 中国药房,2004,15(12):719-720. |
[6]
|
郭洁文,廖惠芳,潘竞锵,等. 荔枝核皂苷改善高脂血症-脂肪肝大鼠胰岛素抵抗作用的机制研究[J]. 中国药房,2005,16(10):732-734. |
[7]
|
郭洁文,潘竞锵,邱光清,等. 荔枝核增强2型糖尿病-胰岛素抵抗大鼠胰岛素敏感性作用[J]. 中国新药杂志,2003,12(7):526-529. |
[8]
|
张汝学,贾正平,李茂星,等. 体外胰岛素抵抗细胞模型的建立及在药物筛选中的应用[J]. 中国药理学通报,2008,24(7):971-976. |
[9]
|
Skoczen S, Wojcik M, Fijorek K, et al. Expression of the central obesity and type 2 diabetes mellitus genes is associated with insulin resistance in young obese children[J]. Exp Clin Endocrinol Diabetes,2015,123(4):252-259. |
[10]
|
Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome[J]. Nature,2001,414(6865):821-827. |
[11]
|
袁 红. 荔枝核多糖提取物对四氧嘧啶致糖尿病小鼠降糖作用[J]. 健康研究,2010,30(4):113-116. |
[12]
|
徐 婷,吴 青,高骏伟. 荔枝核提取物及其阳离子树脂分离物体外降血糖作用 [J]. 食品与机械,2012,28(04):252-255. |
[13]
|
楼忠明,田菊霞,王文香,等. 荔枝核总皂甙提取物对糖尿病小鼠的降糖疗效观察[J]. 浙江医学,2007,29(06):548-549. |
[14]
|
廖向彬,李常青,李小翚,等. 荔枝核有效部位群改善3T3-L1脂肪细胞胰岛素抵抗作用及机制[J]. 中药材,2014(07):1247-1250. |
-
-
Proportional views
-